NCT00003468View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 1996

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Low Grade Astrocytomas
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Children with a low grade astrocytoma that have not responded to standard therapy will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER